Narcolepsy Type 1 Nt1 clinical trials

Explore recruiting narcolepsy type 1 nt1 clinical trials.

Recruiting narcolepsy type 1 nt1 studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Narcolepsy Type 1 Nt1 trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

Sweden, Finland, Belgium, Spain, Netherlands, France +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

Italy, France, Netherlands, Spain, Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

Open-label single dose trial to evaluate pharmacokinetics, safety, and acceptability/palatability of oveporexton in children from 6 years to less than 18 years of age with narcolepsy type 1 (NT1)

Italy

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of E2086 in Adults with Narcolepsy

Belgium, Italy, Spain, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Narcolepsy Type 1 Nt1 trials by city

Narcolepsy Type 1 Nt1 in Toronto Narcolepsy Type 1 Nt1 in Vancouver Narcolepsy Type 1 Nt1 in Montreal Narcolepsy Type 1 Nt1 in Calgary Narcolepsy Type 1 Nt1 in Edmonton Narcolepsy Type 1 Nt1 in Ottawa Narcolepsy Type 1 Nt1 in Winnipeg Narcolepsy Type 1 Nt1 in Quebec City Narcolepsy Type 1 Nt1 in Hamilton Narcolepsy Type 1 Nt1 in Kitchener Narcolepsy Type 1 Nt1 in London Narcolepsy Type 1 Nt1 in Halifax Narcolepsy Type 1 Nt1 in New York Narcolepsy Type 1 Nt1 in Los Angeles Narcolepsy Type 1 Nt1 in Chicago Narcolepsy Type 1 Nt1 in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease